Reily Genomics raises $15,000,000

Reily Genomics Inc. raised $15 million in Series B funding, according to a regulatory filing on Friday.   Reily Genomics, based in Palo Alto, says it integrates diagnostics with therapeutics to identify the right patients for the right medication at the right dose at the right time.